{"organizations": [], "uuid": "2895fc66605caa759611105236f52cf1b9788431", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-eyegate-receives-fda-feedback-on-i/brief-eyegate-receives-fda-feedback-on-investigational-device-exemption-amendment-for-second-pilot-study-of-ocular-bandage-gel-idUSFWN1RM0L7", "country": "US", "domain_rank": 408, "title": "BRIEF-Eyegate Receives FDA Feedback On Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T21:11:00.000+03:00", "replies_count": 0, "uuid": "2895fc66605caa759611105236f52cf1b9788431"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-eyegate-receives-fda-feedback-on-i/brief-eyegate-receives-fda-feedback-on-investigational-device-exemption-amendment-for-second-pilot-study-of-ocular-bandage-gel-idUSFWN1RM0L7", "ord_in_thread": 0, "title": "BRIEF-Eyegate Receives FDA Feedback On Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eyegate pharmaceuticals inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE RECEIVES FDA FEEDBACK ON INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR SECOND PILOT STUDY OF OCULAR BANDAGE GEL\n* IN ITS LETTER, FDA IDENTIFIED FOUR DEFICIENCIES IN COMPANY’S SUBMISSION\n* FDA REQUESTED ADDITIONAL INFORMATION ON MANUFACTURING PROCESSES ASSOCIATED WITH EYEGATE OBG PRODUCT\n* CO TARGETING SUBMISSION OF A SECOND AMENDMENT TO IDE APPLICATION IN JULY 2018\n* IN U.S. FDA’S LETTER, PRIMARY COMMENT RELATES TO VALIDATION OF FILTER SPECIFICALLY USED FOR STERILIZATION OF CMHA MATERIAL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T21:11:00.000+03:00", "crawled": "2018-04-10T12:43:16.026+03:00", "highlightTitle": ""}